$APRN - Coronavirus-Led Panic Confines People to Necessities: 4 Picks: $AYTU - Aytu BioScience, Inc. (AYTU) Shares March Higher, Can It Continue? (3/11/2020): $BMRA - We're Not Very Worried About Biomerica's

$APRN - This Stock Soars 500% As Coronavirus Shutdowns Boost Home Cooking: $BMRA - The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates: $DWT

$APRN - Blue Apron Soars as Cities Curtail Restaurants, Shoppers Panic: $CODX - Justin Anderson, CEO of PreCheck Health Services, Inc. is Featured in a New Interview at SmallCapVoice.com: $NVAX - Vaxart:

$AYTU - Aytu BioScience's Coronavirus Rapid Test Featured on NBC and Fox News (VIDEOS): ''Englewood Company Says It Can Get COVID-19 Test Results in 2-10 Minutes"; "2-Minute COVID-19 Test Results?

$BRZU - Brazil ETFs Trade at Trendline Support (2/12/2020): $IBIO - iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO: $LJPC - La Jolla Pharmaceutical Company to Provide

$APT - Benzinga Pro's Top 5 Stocks To Watch For Thurs., Mar. 12, 2020: BA, APT, UBER, APRN, CHFS: $AYTU - Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?: $CODX - Stocks nosedive as

$AIM - AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human

$AYTU - Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test: $BNGO - Bionano Genomics Will Be Used in Research Identifying Gene Variants

$BCRX - BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates: $CANF - Can-Fite Updates on Clinical Milestone for its Phase III Rheumatoid Arthritis Study with Piclidenoson; Drugs Combating

$AIM - Inovio shares rally after biotech says human trials of coronavirus vaccine will start in April: $APOP - Nano-Cap Cellect Biotechnology Rips Higher On Medical Cannabis Deal: $CTRM - Castor Maritime

$GNMK - GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates: $MITO - FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth

$APDN - Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines For Animal Testing: $CODX - Co-Diagnostics CEO on FDA's coronavirus policy changes: $CPHI - China Pharmaceutical Holdings Co., Ltd.

$AHPI - Penny Stocks To Watch After Coronavirus Comments: $AIM - AIM ImmunoTech Joins with ChinaGoAbroad for an Ampligen China Entry Against COVID-19, the New SARS-like Coronavirus Disease Epidemic: $APT

$APT - CORRECTION -- Alpha Pro Tech, Ltd. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2019: $CODX - The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics,

$COCP - Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds: $LL - Lumber Liquidators Reports Q4 Earnings

$NGM - NGM Bio Announces Positive Preliminary Topline Liver Histology and Biomarker Data from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in NASH Patients, Including Statistically Significant Achievement

$Z & $ZG - Earnings